Diversity of calcium antagonists
- 1 January 1997
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 19, 3-17
- https://doi.org/10.1016/s0149-2918(97)80033-1
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Antihypertensive Properties of the Novel Calcium Antagonist Mibefradil (Ro 40-5967)Hypertension, 1996
- Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: A multicenter, placebo-controlled studyAmerican Heart Journal, 1995
- AmlodipineDrugs, 1995
- Mibefradil Prevents Neointima Formation After Vascular Injury in RatsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Different negative inotropic activity of Ca2+-antagonists in human myocardial tissueJournal of Molecular Medicine, 1990
- The structurally novel Ca2+ channel blocker Ro 40-5967, which binds to the [3H] desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat heartsCardiovascular Drugs and Therapy, 1990
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- Effect of nifedipine on renal function in patients with essential hypertension.Hypertension, 1988
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Long-term renal effects of diltiazem in essential hypertensionAmerican Heart Journal, 1987